191 related articles for article (PubMed ID: 16968516)
1. Crohn's disease in common variable immunodeficiency: treatment with antitumor necrosis factor alpha.
Nos P; Bastida G; Beltran B; Aguas M; Ponce J
Am J Gastroenterol; 2006 Sep; 101(9):2165-6. PubMed ID: 16968516
[No Abstract] [Full Text] [Related]
2. Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease.
Sorrentino D; Terrosu G; Vadalà S; Avellini C
Digestion; 2007; 75(1):22-4. PubMed ID: 17429204
[No Abstract] [Full Text] [Related]
3. [Anti-TNF therapy and Crohn's disease].
Peyrin-Biroulet L
Gastroenterol Clin Biol; 2008 May; 32(5 Pt 1):478-81. PubMed ID: 18439777
[No Abstract] [Full Text] [Related]
4. The management of fistulizing oral Crohn's disease with infliximab.
Staines KS; Green R; Felix DH
J Oral Pathol Med; 2007 Aug; 36(7):444-6. PubMed ID: 17617840
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
[TBL] [Abstract][Full Text] [Related]
6. [Perianal fistulas in Crohn's disease--biologicals and surgery: is it worthwhile?].
Bode M; Eder S; Schürmann G
Z Gastroenterol; 2008 Dec; 46(12):1376-83. PubMed ID: 19053007
[TBL] [Abstract][Full Text] [Related]
7. How deep is remission in perianal Crohn's disease and do imaging modalities matter?
Savoye G; Savoye-Collet C
Am J Gastroenterol; 2010 Jun; 105(6):1445-6; author reply 1446. PubMed ID: 20523317
[No Abstract] [Full Text] [Related]
8. [When should anti-TNF-alpha treatment in Crohn disease be terminated?].
Moum B
Tidsskr Nor Laegeforen; 2010 Mar; 130(5):474. PubMed ID: 20224609
[No Abstract] [Full Text] [Related]
9. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
[TBL] [Abstract][Full Text] [Related]
10. Infliximab in fistulizing Crohn's disease.
Osterman MT; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814
[TBL] [Abstract][Full Text] [Related]
11. Atypical mycobacteria: showerheads, anti-TNF therapy and Crohn's disease.
Desai AA; Marks DJ
Expert Rev Clin Immunol; 2010 Sep; 6(5):695-9. PubMed ID: 20828275
[No Abstract] [Full Text] [Related]
12. Treatment of Crohn's disease at the turn of the century.
Bickston SJ; Cominelli F
N Engl J Med; 1998 Aug; 339(6):401-2. PubMed ID: 9691110
[No Abstract] [Full Text] [Related]
13. [Common variable immunodeficiency and sarcoidosis: what is the link?].
Agostini C; Semenzato G
Ann Ital Med Int; 2002; 17(2):77-80. PubMed ID: 12150049
[No Abstract] [Full Text] [Related]
14. Medical therapy for refractory pediatric Crohn's disease.
Faubion WA; Bousvaros A
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1199-213. PubMed ID: 16872913
[TBL] [Abstract][Full Text] [Related]
15. Rheumatic fever in a patient receiving infliximab therapy for Crohn disease.
Abu-El-Haija M; Stasheff S; Atkins DL; Bishop WP
J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):360-1. PubMed ID: 21150656
[No Abstract] [Full Text] [Related]
16. [When can TNF-alpha inhibitors against inflammatory bowel disease be withdrawn?].
Moum B
Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1673. PubMed ID: 17571118
[No Abstract] [Full Text] [Related]
17. Biologic therapy in Crohn's disease.
Williams MD; Omran ML; Gordon GL
Mo Med; 2009; 106(5):356-60. PubMed ID: 19902717
[TBL] [Abstract][Full Text] [Related]
18. Anti-TNF-alpha for treatment of amyloidosis associated with Crohn's disease.
Fernández-Nebro A; Ureña I; Irigoyen MV; García-Vicuña R
Gut; 2006 Nov; 55(11):1666-7; author reply 1667. PubMed ID: 17047117
[No Abstract] [Full Text] [Related]
19. Postoperative Crohn's disease: prevention and treatment.
El-Hachem S; Regueiro M
Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):249-56. PubMed ID: 19485807
[TBL] [Abstract][Full Text] [Related]
20. [Is Crohn's disease an indication for growth hormone treatment?].
Szalecki M; Ziora K
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):237-40. PubMed ID: 17020663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
